Coming Into Resistance: Clinically Important Antibiotic Resistance Genes in NICU vs. Healthy Infants
Rachel E Strength, Angelina Angelova, Emily Robbins, Shira Levy, Kathryn E McCauley, Kevin M Lloyd, Elisa B Margolis, Andrew S Burns, Shreni Mistry, Poorani Subramanian, Aimee Dassner, Christa Zerbe · 2026
Read Coming Into Resistance: Clinically Important Antibiotic Resistance Genes in NICU vs. Healthy Infants by Rachel E Strength, Angelina Angelova, Emily Robbins, Shira Levy, Kathryn E McCauley, Kevin M Lloyd, Elisa B Margolis, Andrew S Burns, Shreni Mistry, Poorani Subramanian, Aimee Dassner, Christa Zerbe (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13648756.txt.
Description
Rachel E. Strength and colleagues track drug-proof genes in the guts of babies who start life in a newborn intensive care unit. Sick babies often catch germs from their own gut, so proof genes there can shape drug choice. The team read stool DNA from 179 babies, from birth to age three.
One thousand stool samples came from two studies. Babies were split four ways: care unit or well-baby ward, and drugs in the first two months or none. Eleven key proof genes split the groups over time. Levels ran high early in care unit babies, with or without early drugs. The work maps how proof genes take hold in the first years of life.
Catalog record
| CREATOR | Rachel E Strength, Angelina Angelova, Emily Robbins, Shira Levy, Kathryn E McCauley, Kevin M Lloyd, Elisa B Margolis, Andrew S Burns, Shreni Mistry, Poorani Subramanian, Aimee Dassner, Christa Zerbe |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 4 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |